1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

About 7000 reports for Lymphoma (page 3)

Purchase Reports From Reputable Market Research Publishers

Global Blood Cancer Therapeutics Market 2019-2023

  • $ 2500
  • February 2019
  • 119 pages

Most of the drugs are being developed for both lymphoma and leukemia, thus leading to more vendors entering the market to research on novel therapies.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Forecast

Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026

  • $ 2800
  • April 2019
  • 1200 pages

Lymphomas (US$), July 2018 Figure ##-##: US – Yescarta Target Dose vs Maximum Dose of CAR-positive viable T cells, October 2017 Figure ##-##: US - Yescarta & Kymriah Overall Treatment Cost (US$), April 2018 Figure ##-##: US - Yescarta & Kymriah Estimated Payment Rate by Centers for Medic

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • United States
  • World

Global Hematologic Malignancies Testing Market: Focus on Product, Disease, Technology, End User, Region/Country Data and Competitive Landscape – Analysis and Forecast, 2019-2025

  • $ 5000
  • November 2019
  • 198 pages

The hematologic malignancies testing market segmentation (on the basis of disease) is segmented into leukemia, lymphoma, multiple myeloma, myeloproliferative neoplasms, and myelodysplastic syndromes.

  • Cancer
  • Lymphoma
  • Pathology
  • World

Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026

  • $ 3000
  • January 2020
  • 1500 pages

Lymphoma for ACT Gene Therapy Program ##.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020

  • $ 3495
  • April 2020
  • 400 pages

Lymphoma Society, LifeLink Foundation, LifeLiver, LifeQ, LineaRx, Lipidor, LogicNets, Loreal, Louisiana State University, Loxo Oncology, Lupin Limited, Luye Pharma Group, Macrogen, MAKScientific, Mallinckrodt Pharmaceuticals, Marina Biotech, Marshall Institute for Interdisciplinary Research

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Betalutin

  • $ 10000
  • January 2019
  • 17 pages

CD## is highly expressed in B cells and B-cell lymphomas.

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Aliqopa

  • $ 10000
  • January 2019
  • 18 pages

Aliqopa CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Aliqopa : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Aliqopa for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Aliqopa for follicular

  • Cancer
  • Lymphoma
  • Pathology
  • Targeted Therapy
  • Therapy

INCB050465

  • $ 10000
  • January 2019
  • 16 pages

INCB## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## INCB## : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: INCB## for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of INCB## for folli

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • Forecast

umbralisib

  • $ 10000
  • January 2019
  • 26 pages

umbralisib CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## umbralisib : NHL: Follicular lymphoma (FL) ## umbralisib : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Umbralisib for follicular lymphoma – SWOT analysis ## Figure ##: Datamo

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

lisocabtagene maraleucel

  • $ 10000
  • January 2019
  • 30 pages

lisocabtagene maraleucel CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## lisocabtagene maraleucel : NHL: Follicular lymphoma (FL) ## lisocabtagene maraleucel : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Lisocabtagene maraleucel for follicula

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Pathology

Yescarta

  • $ 10000
  • January 2019
  • 19 pages

Yescarta CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Yescarta : NHL: Follicular lymphoma (FL) ## Yescarta : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Yescarta for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor H

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Pathology

Blood Testing: Technologies and Global Markets

  • $ 5500
  • October 2018
  • 224 pages

Lymphoma, 2018 Figure ## : Global Market for Blood Disorder Testing, by Region, 2017-2023 Figure ## : Global Market for Pregnancy Blood Testing, by Region, 2017-2023 Figure ## : Cardiovascular Disease Mortality, by Disease Area, 2017 Figure ## : Global Market for Cardiovascular Blood Testin

  • Diagnostics
  • Lymphoma
  • World

NORTH AMERICA AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET FORECAST 2019-2027

  • $ 1250
  • August 2019
  • 89 pages

LYMPHOMA IN THE UNITED STATES, 2019 (%) FIGURE ## NORTH AMERICA AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET SHARE, BY PRODUCT TYPE, 2018 & 2027 (%) FIGURE ## NORTH AMERICA AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY DEVICES, 2019-2027 ($ MILLION) FIGURE ## NORTH AMERICA AUTOTRANS

  • Cancer
  • Lymphoma
  • North America

Revlimid

  • $ 10000
  • January 2019
  • 56 pages

Revlimid CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Revlimid : NHL: Follicular lymphoma (FL) ## Revlimid : NHL: Diffuse large B-cell lymphoma (DLBCL) ## Revlimid : Multiple myeloma ## Revlimid : NHL: Mantle cell lymphoma (MCL) LIST OF FIGURES ## Figur

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • Japan

Global Cancer Therapies Industry

  • $ 5450
  • January 2020
  • 915 pages

s Lymphoma ## Leukemia ## Standard Approved Mode of Therapy for AML by Age Group ## Blood Cancer Phase IV Completed Clinical Trials with Results: As of Dec ##, 2019 ## Blood Cancer Phase III Completed Clinical Trials with Results: As of Dec ##, 2019 ## Bladder Cancer ## Endometrial Cancer ##

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • Market Shares

Companion Diagnostics Services Market, 2020-2030

  • $ 4899
  • January 2020
  • 350 pages

Lymphoma by Affiliated Biomarkers Figure ##. ## Clinical Trial Analysis: Distribution of Trials of the Ovarian Cancer by Affiliated Biomarkers Figure ##. ## Clinical Trial Analysis: Distribution of Trials of the Prostate Cancer by Affiliated Biomarkers Figure ##. ## Clinical Trial Analysis: Di

  • Biomarker
  • Clinical Trial
  • Diagnostics
  • Lymphoma
  • World

Global Oncology Partnering 2014-2020: Deal trends, players and financials

  • $ 3495
  • May 2020
  • 2500 pages

Lymphoma, Hodgkin’s lymphoma, Non Hodgkin’s lymphoma, Melanoma, Mesothelioma, Metastases, Bone metastases, Multiple myeloma, Neuroblastoma, Non-melanoma skin cancer, Ovarian cancer, Pancreatic cancer, Prostate cancer, Renal cell carcinoma, Sarcoma, Solid tumors, Testicular cancer, Thyroid c

  • Lymphoma
  • Orphan Disease
  • Pharmaceutical
  • Therapy
  • United States

EUROPE AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET FORECAST 2019-2027

  • $ 1250
  • August 2019
  • 90 pages

LYMPHOMA IN THE UNITED STATES 2019 (%) FIGURE ## EUROPE AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%) FIGURE ## EUROPE AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY DEVICES, 2019-2027 ($ MILLION) FIGURE ## EUROPE AUTOTRANSFUSION DEVICES AND CONSU

  • Cancer
  • Lymphoma
  • Europe

Gene Therapy Market Size, Share & Trends Analysis Report By Indication, By Vector Type, By Region And Segment Forecasts, 2020 - 2027

  • $ 5950
  • February 2020
  • 160 pages

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type, By Region, And Segment Forecasts, 2020 - 2027 The global gene therapy market size is expected to reach USD ##. ## billion by 2027, at a CAGR of ##.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • United States
  • Market Size

NHL: Diffuse large Bcell lymphoma

  • $ 5000
  • May 2016
  • 219 pages

Immunophenotyping also needs to be robust enough to distinguish the disease from other lymphomas which resemble DLBCL in morphology, such as mantle cell lymphoma and Burkitt' s lymphoma.

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on